TCT 2019 Breakfast Symposium PROTECT III Presentation
New PROTECT III Data Demonstrates Impella®
Reduces MACCE at Primary Endpoint
Jeffrey J. Popma, MD, presents new data from ongoing FDA post-approval study for PROTECT II RCT
Follow us on Twitter at @ProtectedPCI.
Subscribe here for exclusive updates from ProtectedPCI.com